Carles Iniesta, a pharmacist at the Hospital Universitario Reina Sofía in Murcia, is the lead author of the study 'Biosimilar infliximab CPT-13 for inflammatory bowel disease in a real clinical setting: pharmacokinetic outcomes, immunogenicity, and drug survival', which has received the Enrique Award Gelabert, from the Royal Academy of Medicine and Surgery of the Region of Murcia.